- Home
- AMST vs CDIO Comparison
AMST vs CDIO Comparison
Compare AMST & CDIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AMST
- CDIO
- Stock Information
- Founded
- AMST 2017
- CDIO 2017
- Country
- AMST United States
- CDIO United States
- Employees
- AMST N/A
- CDIO N/A
- Industry
- AMST Computer Software: Prepackaged Software
- CDIO Biotechnology: Commercial Physical & Biological Resarch
- Sector
- AMST Technology
- CDIO Health Care
- Exchange
- AMST Nasdaq
- CDIO Nasdaq
- Market Cap
- AMST 9.5M
- CDIO 7.9M
- IPO Year
- AMST 2020
- CDIO N/A
- Fundamental
- Price
- AMST $2.65
- CDIO $3.44
- Analyst Decision
- AMST
- CDIO Buy
- Analyst Count
- AMST 0
- CDIO 1
- Target Price
- AMST N/A
- CDIO $60.00
- AVG Volume (30 Days)
- AMST 41.9K
- CDIO 57.8K
- Earning Date
- AMST 05-15-2025
- CDIO 08-11-2025
- Dividend Yield
- AMST N/A
- CDIO N/A
- EPS Growth
- AMST N/A
- CDIO N/A
- EPS
- AMST N/A
- CDIO N/A
- Revenue
- AMST $82,544.00
- CDIO $19,902.00
- Revenue This Year
- AMST N/A
- CDIO $1,434.82
- Revenue Next Year
- AMST N/A
- CDIO $4,661.91
- P/E Ratio
- AMST N/A
- CDIO N/A
- Revenue Growth
- AMST N/A
- CDIO N/A
- 52 Week Low
- AMST $2.00
- CDIO $3.22
- 52 Week High
- AMST $6.27
- CDIO $53.10
- Technical
- Relative Strength Index (RSI)
- AMST 45.78
- CDIO 32.36
- Support Level
- AMST $2.67
- CDIO $3.65
- Resistance Level
- AMST $2.72
- CDIO $4.18
- Average True Range (ATR)
- AMST 0.15
- CDIO 0.31
- MACD
- AMST -0.05
- CDIO 0.12
- Stochastic Oscillator
- AMST 26.89
- CDIO 4.49
About AMST Amesite Inc.
Amesite Inc is an artificial intelligence-driven platform and course designer that rapidly provides customized, high-performance and scalable online products for schools and businesses. The company helps educational institutions and businesses improve learning as their technology partner, delivering a disruptive technology driven by AI and offers a constellation of services that help partners implement new programs, and improve existing ones. Its customers are Enterprises, universities, and K-12 schools.
About CDIO Cardio Diagnostics Holdings Inc. Common stock
Cardio Diagnostics Holdings Inc is a medical technology company focused on developing and commercializing epigenetics-based clinical tests for cardiovascular diseases. The company offers three AI-powered solutions for the risk assessment, detection, management, and monitoring of coronary heart diseases. These solutions are Epi+Gen CHD, a symptomatic CHD risk assessment clinical blood test targeting CHD events; PrecisionCHD, an integrated epigenetic-genetic clinical blood test for the detection of coronary heart disease; and Actionable Clinical Intelligence, a platform coupled to the Epi+Gen CHD and PrecisionCHD tests that provide personalized insights by linking the epigenetic and genetic biomarkers evaluated by these tests to the drivers of coronary heart disease.